depth
discuss
virus
implic
ms
pathogenesi
first
consid
virus
greatest
evid
base
name
epsteinbarr
viru
ebv
human
herpesviru
vzv
human
endogen
retrovirus
herv
go
describ
potenti
role
minor
virus
ms
focu
connect
virus
ms
pathophysiolog
rather
clinic
progress
highlight
limit
exist
studi
possibl
futur
research
direct
pubm
googl
scholar
databas
search
articl
publish
appear
epub
ahead
print
januari
decemb
bibliographi
examin
initi
screen
multipl
sclerosi
infecti
caus
viru
viral
model
appli
boolean
oper
specif
term
appli
differ
section
review
base
relev
infecti
agent
one
name
relev
search
term
appli
prioriti
given
origin
research
articl
systemat
reviewsmetaanalys
case
report
hypothesisviewpoint
articl
recent
paper
applic
refer
prior
time
period
includ
given
histor
import
studi
refer
paediatr
ms
infecti
agent
virus
publish
english
exclud
live
ongo
debat
role
ebv
prevail
ms
infecti
risk
factor
ms
pathogenesi
one
hypothesi
suggest
ms
caus
genet
predispos
defici
elimin
previou
ebv
infect
ebv
persist
accumul
even
establish
brain
patient
consist
theori
ebv
might
exercis
strong
influenc
number
andor
memori
b
cell
differenti
statu
compet
hypothesi
abnorm
respons
ebv
infect
secondari
caus
ms
epidemiolog
level
sever
systemat
review
clearli
support
associ
ms
ebv
seroposit
practic
ms
patient
ebv
seroposit
rais
question
whether
ebvseroneg
ms
patient
even
exist
ebv
seroposit
confer
doubl
risk
ms
infecti
mononucleosi
im
vs
respect
im
appear
stronger
genet
compon
ebv
infect
howev
reason
differ
risk
ebv
seroposit
im
might
due
report
bia
im
ii
molecular
stochast
ebvinduc
downstream
event
iii
role
ebv
latenc
importantli
iv
subclin
infect
high
epsteinbarr
viru
nuclear
antigen
ebna
igg
titr
associ
ms
risk
factor
nonhla
gene
loci
allel
import
genet
factor
ms
cell
restrict
allel
link
msrelat
antigen
seem
crossreact
immunolog
respons
induc
sequenc
howev
latest
metaanalysi
reveal
addit
synergist
effect
two
risk
factor
corrobor
carriag
confound
factor
ebv
ms
highli
synergist
increas
ms
risk
report
ebv
detect
im
combin
obes
notabl
adolesc
howev
conflict
result
interact
ebv
wellestablish
ms
risk
factor
review
also
instanc
prospect
studi
found
posit
associ
smoke
ms
develop
older
patient
neg
one
patient
less
around
year
old
wherea
later
casecontrol
studi
report
neg
multipl
interact
im
histori
prior
histori
smoke
ms
risk
regard
vitamin
studi
fail
detect
statist
signific
interact
other
report
interact
either
ebv
antibodi
dna
load
mechanist
observ
overlap
vitamin
receptor
vdr
bind
site
within
msassoci
genom
region
bind
vdr
may
provid
insight
neuroimag
studi
mri
magnet
reson
imag
marker
ms
activ
grey
matter
atrophi
found
associ
antiebv
antibodi
level
cellular
level
cell
specif
ebv
lytic
latent
antigen
frequent
patient
activ
inact
ms
respect
deep
sequenc
tcell
gene
immunosequenc
show
intrathec
enrich
ebvreact
cell
specif
patient
ms
furthermor
anim
model
use
lymphocryptoviru
lcv
close
rel
ebv
lcvinfect
b
cell
lost
abil
process
extrins
pathogen
tcell
epitop
myelin
oligodendrocyt
glycoprotein
mog
crosspres
epitop
autoaggress
cytotox
lymphocyt
reaction
initi
autoimmun
reaction
demyelin
regard
humor
immun
high
antibodi
titr
ebna
protein
patient
ms
might
due
intrathec
synthesi
yet
clarifi
whether
result
highfrequ
latent
ebvinfect
cell
altern
concret
pathogen
role
convers
patient
im
show
activ
mogspecif
memori
b
cell
furthermor
ebv
genet
materi
identifi
csf
perivenular
infiltr
brain
spinal
cord
white
matter
recent
cortic
grey
matter
cervic
lymph
node
patient
ms
ebv
brain
infect
like
limit
small
number
b
cell
approxim
per
memori
b
cell
could
explain
histolog
studi
detect
difficult
underscor
need
technolog
massiv
parallel
singlecel
sequenc
detect
rare
event
futur
dual
infect
ebv
type
common
patient
ms
compar
singl
infect
mechanist
ebv
might
act
environment
trigger
attack
cn
respect
former
eae
model
murin
ebv
homologu
gammaherpesviru
show
pronounc
mslike
clinicopatholog
featur
depend
latent
life
cycl
viru
number
theori
regard
latter
mechan
direct
cn
destruct
viru
ms
result
ebv
infect
autoreact
b
cell
turn
produc
pathogen
autoantibodi
iv
mistaken
self
hypothesi
base
proteom
analys
show
higher
frequenc
peptid
correspond
region
share
homolog
nterminu
patient
ms
overal
understand
mechan
pave
way
novel
antim
strategi
notabl
ebvspecif
adopt
immunotherapi
also
mechanist
intrigu
ebv
play
role
cancera
disord
cellular
proliferationand
msa
diseas
character
neuron
cell
death
howev
recent
report
genet
overlap
ebvrel
hodgkin
lymphoma
ms
could
shed
light
parallel
dogma
ebv
possibl
found
glial
cell
neuron
host
immun
respons
must
remain
focu
studi
ebv
latenc
statu
underpin
virusmedi
pathogenesi
reexamin
light
recent
observ
ebv
caus
lytic
infect
human
primari
neuron
summar
context
discord
high
rate
ebv
infect
vs
low
rate
ms
worldwid
ebv
like
necessari
suffici
caus
ms
futur
studi
share
polygen
risk
genomewid
associ
studi
ms
case
marker
increas
ebv
level
eg
like
shed
light
hostpathogen
interact
recent
inconclus
nonsystemat
summari
evid
role
ms
highlight
need
formal
metaanalysi
topic
furthermor
although
detect
mostli
acut
demyelin
brain
lesion
ms
detect
rate
highli
variabl
dna
csf
rang
patient
addit
marker
bor
tcell
reactiv
higher
antibodi
respons
higher
viral
load
consist
observ
ms
patient
serum
differ
ethnic
group
prospect
studi
specif
singl
nucleotid
polymorph
snp
eg
strongli
associ
activ
replic
togeth
wors
clinic
prognosi
ms
edg
geneenviron
interact
lie
herv
see
one
subtyp
shown
activ
mainli
cell
line
product
infect
viru
follow
latent
infect
viru
observ
reinforc
notion
common
hervmedi
pathway
downstream
viral
infect
ms
might
therapeut
exploit
marmoset
callithrix
jacchu
model
use
studi
viral
neurotrop
interestingli
contrast
viru
seem
gain
entri
human
cn
via
olfactori
pathway
find
marmoset
reveal
intraven
intranas
inocul
develop
neurolog
diseas
furthermor
contrast
global
seropreval
frequent
patient
ms
certainli
worthi
investig
infect
lead
apoptosi
brain
induc
autoimmun
sever
way
activ
antivir
gene
human
astrocyt
includ
gene
upregul
ms
varicella
zoster
viru
vzv
induc
encephalomyel
character
demyelin
similar
seen
ms
vzv
suggest
mstrigger
factor
howev
epidemiolog
studi
report
associ
histori
varicella
infect
childhood
ms
risk
other
observ
associ
notabl
relapseremit
rr
secondari
progress
type
fourfold
increas
ms
risk
year
follow
herp
zoster
infect
observ
region
low
ms
preval
regrett
serolog
molecular
studi
help
much
area
vzv
seroposit
significantli
higher
patient
ms
vs
control
two
studi
moreov
vzv
dna
identifi
csf
patient
ms
particularli
rr
type
studi
other
fail
confirm
find
csf
blood
acut
ms
lesion
consist
howev
observ
high
level
vzv
dna
csf
pbmc
relaps
ultim
disappear
clinic
remiss
interestingli
progress
ms
type
associ
vzv
dna
level
found
relaps
remiss
period
rrm
type
median
fraction
intrathec
vzvspecif
igg
total
igg
differenti
patient
ms
vzv
reactiv
higher
latter
observ
impli
lowlevel
infect
present
least
ms
case
also
help
address
whether
vzv
detect
ms
due
reactiv
previous
latent
vzv
infect
centripet
infect
neural
ganglia
toward
cn
anoth
theori
suggest
vzv
ms
pure
epiphenomen
due
leakag
destroy
sensori
neuron
howev
experiment
evid
lack
also
vzv
identifi
tradit
autoimmun
diseas
impli
specif
connect
ms
final
vzv
antigen
induc
maintain
activ
herv
peripher
lymphocyt
patient
ms
compar
control
retrovirus
explain
implic
causal
ms
although
initi
implic
ms
patholog
sinc
subsequ
studi
continu
support
role
endogen
rather
exogen
retrovirus
ms
herv
integr
human
genom
rel
recent
evolutionari
term
million
year
ago
result
ancestr
retrovir
infect
human
form
genom
constitut
notabl
categori
long
termin
repeat
ltr
retrotransposon
transpos
element
also
known
jump
gene
chang
posit
within
genom
repetit
sequenc
explain
difficult
investig
inherit
classic
genet
approach
despit
difficulti
estim
transcript
factor
bind
site
tfbss
regul
herv
underscor
genomewid
role
deciph
pathophysiolog
role
offer
insight
molecular
basi
diseas
beyond
offer
focus
exclus
exom
put
mechan
hervrel
pathophysiolog
ms
illustr
figur
also
establish
bodi
evid
envelop
protein
msassoci
retroviru
msrvenv
hervw
famili
causal
ms
initi
observ
leptomening
cell
mrsvenv
protein
detect
ms
plaqu
contain
macrophag
microglia
perivascular
cell
activ
demyelin
lesion
astrocyt
inact
area
control
brain
high
mrsvenv
dna
copi
number
transcript
antigen
level
recent
detect
blood
patient
ms
increas
dna
copi
number
indic
hervrel
revers
transcriptas
activ
earlier
studi
suggest
potenti
mrsvenv
select
ms
brain
observ
viral
genet
materi
present
higher
level
brain
blood
patient
hervw
env
express
also
increas
surfac
b
cell
monocyt
activ
phase
ms
parallel
ms
exacerb
protein
tolllik
receptor
agonist
stimul
immun
cell
enhanc
express
marker
leucocyt
adhes
endotheli
cell
rais
interest
question
effect
mrsvenv
bloodbrain
barrier
integr
parallel
hervw
env
impair
remyelin
inhibit
differenti
oligodendrocyt
precursor
myelinproduc
oligodendrocyt
potenti
due
nitros
stress
hervw
glycoprotein
also
seem
implic
ms
via
similar
mechan
caus
endoplasm
reticulum
stress
sensor
induc
induc
nitric
oxygen
synthas
concomitantli
releas
oligodendrocyt
cytotoxin
astrocyt
detail
see
also
herv
induc
eae
mice
impli
role
upstream
mediat
therefor
herv
seem
implic
neuroinflammatori
neurodegen
compon
diseas
render
promis
therapeut
target
autoimmun
mechan
may
also
lie
fact
common
virus
includ
limit
ebv
influenza
activ
herv
protein
tabl
dual
infect
ebv
may
exogen
delay
caus
ms
hervw
act
precipit
howev
mechan
transcript
activ
herv
gener
obscur
downstream
event
human
cell
gener
framework
might
herv
broadli
endogen
transposon
act
genom
defenc
respons
extern
stimuli
studi
fail
find
differ
presenc
herv
nucleic
acid
antibodi
ms
case
control
cell
serolog
respons
may
associ
autoimmun
although
causal
yet
establish
c
herv
integr
human
genom
epigenet
inactiv
normal
condit
herv
express
may
induc
environment
trigger
includ
vzv
ebv
virus
stimul
immun
respons
autoimmun
mrsvenv
protein
identifi
ms
plaqu
brain
select
immunopathogen
may
directli
stimul
autoimmun
respons
tcell
respons
hiv
knowledg
less
twenti
hiv
case
report
describ
demyelin
cn
diseas
includ
ms
disturb
cytotox
tcell
regulatori
cell
ratio
implic
causal
rariti
document
case
hiv
ms
consist
largest
relev
record
linkag
studi
hiv
patientsal
presum
undergon
highli
activ
antiretrovir
therapi
haart
therapywer
statist
signific
reduc
risk
rel
develop
ms
rel
risk
includ
record
time
interv
first
hiv
record
first
ms
record
one
explan
find
could
hivinduc
immunodefici
protect
ms
altern
haart
usual
employ
competit
noncompetit
revers
transcriptas
rt
inhibitor
due
suspect
similar
hiv
rt
virus
like
herv
inhibitor
might
suppress
express
latter
major
epidemiolog
studi
cmv
ms
underpow
inconclus
two
synchron
differ
metaanalys
suggest
protect
role
cmv
seroposit
ms
molecular
level
seem
cmv
present
cn
includ
ms
case
exacerb
protect
role
propos
exampl
cmvand
brainspecif
b
cell
histolog
ie
sever
inflammatori
cell
infiltr
final
cmv
betaherpesvirina
subfamili
ebv
gammaherpesvirina
subfamili
might
oppos
regard
downstream
immun
cascad
socal
immun
respons
competit
might
explain
invers
epidemiolog
pattern
ms
also
suggest
herpesvirida
virus
could
requir
elicit
primatespecif
autoimmun
pathway
associ
measl
viru
ms
investig
year
ms
postul
host
respons
later
measl
infect
howev
measl
vaccin
associ
ms
indic
measl
viru
probabl
connect
ms
support
evid
measl
vaccin
safe
despit
unjustifi
wellpublic
claim
contrari
howev
worth
mention
two
cn
complic
measl
viru
infect
manifest
featur
demyelin
acut
dissemin
encephalomyel
differenti
diagnosi
paediatr
ms
rare
subacut
scleros
panenceph
knowledg
recent
research
area
focus
associ
virusspecif
csftoserum
antibodi
indic
ai
ms
viru
detect
use
molecular
techniqu
ai
measl
rubella
vzv
form
mrz
reaction
highspecif
marker
rulingin
ms
review
twofold
higher
ebv
particular
measl
ai
higher
patient
lesion
mri
fewer
lesion
earli
ms
anoth
studi
show
antimeasl
viru
antibodi
titr
serum
csf
patient
ms
increas
accord
age
durat
diseas
phylogenet
close
rinderpest
viru
shown
demyelin
even
neurotrop
rumin
host
interestingli
axon
damag
preced
demyelin
prompt
question
role
inflamm
astrocyt
intermedi
player
lymphocyt
choriomening
viru
lcmv
affect
human
cn
caus
paralysi
reduc
conscious
howev
investig
role
ms
difficult
due
low
titr
short
presenc
lcmv
csf
opinion
might
indic
hitandrun
mechan
hand
recent
silico
predict
show
high
sequenc
structur
similar
lcmv
nucleoprotein
specif
myelin
basic
protein
mbp
residu
murin
model
chronic
lcmv
infect
given
rise
two
nobel
prize
viru
thought
activ
microglia
astrocyt
cn
via
cascad
moreov
lcmv
block
induct
type
interferon
consequenti
upregul
hla
class
ii
observ
support
potenti
virusinduc
disturb
interferontumour
necrosi
factor
balanc
alreadi
known
trigger
autoimmun
interestingli
lcmv
infect
limit
peripheri
concurr
cn
measl
viru
infect
induc
cn
patholog
via
lcmvspecif
tcell
recruit
brain
without
need
lcmv
replic
underli
reason
brain
broadli
consid
immunoprivileg
attract
misrecruit
cell
need
explor
rodent
certain
coronavirusfamili
mous
hepat
viru
strain
neurotrop
disrupt
bloodbrain
barrier
caus
immunemedi
demyelinatinglik
lesion
human
coronavirus
hcov
predominantli
caus
upper
respiratori
tract
infect
also
neurotrop
recent
epidemiolog
studi
lack
molecular
analys
shown
hcovspecif
surfac
glycoprotein
act
trigger
program
cell
death
murin
model
neurodegener
addit
crossreact
cell
isol
patient
ms
singlecel
analys
impli
molecular
mimicri
mechan
review
see
mous
model
encephalomyelitisdemyelin
induc
gliatrop
murin
coronaviru
initi
activ
accumul
selfreact
cell
follow
mechan
hostmedi
suppress
consequenti
led
declin
thu
diminish
autoimmun
phenotyp
saffold
viru
safv
picornavirida
famili
member
identifi
first
human
viru
cardioviru
genu
describ
safv
seropreval
adult
popul
known
caus
infect
earli
life
safv
associ
enter
extraintestin
diseas
due
homolog
tmev
implic
ms
howev
ubiqu
creat
difficulti
deciph
associ
safv
ms
safv
detect
csf
sampl
patient
ms
one
hypothesi
safv
might
caus
lowgrad
persist
infect
follow
inflamm
rather
act
hitandrun
trigger
autoimmun
howev
recent
studi
fail
find
safv
ms
brain
rare
safvspecif
oligoclon
band
patient
ms
differ
control
therefor
accumul
evid
virus
may
trigger
caus
ms
organ
immun
system
interact
sever
potenti
overlap
way
deciph
epidemiolog
contribut
virus
ms
along
pathogen
mechan
may
help
develop
effect
target
therapi
develop
vaccin
treat
diseas
prevent
relaps
maintain
remiss
possibl
futur
research
avenu
includ
prospect
studi
monitor
care
defin
group
patient
compar
patient
clinic
isol
syndrom
ci
went
convert
ms
although
ebv
studi
case
broader
caus
role
virus
would
strengthen
marker
viral
presenc
ie
increas
viral
load
andor
higher
antivir
respons
observ
first
categori
furthermor
band
tcell
receptor
repertoir
ms
sampl
need
fulli
character
prefer
relat
viral
detect
burden
perhap
use
newer
highthroughput
technolog
deep
sequenc
would
facilit
enrich
immunosequenc
databas
extens
experiment
data
repertoir
induc
differ
human
virus
would
also
sensibl
examin
latenttolyt
switch
potenti
exist
virus
ms
biopsi
complement
previou
effort
focus
ebvspecif
marker
would
interest
analys
recent
propos
marker
cellular
antivir
respons
respect
switch
final
given
mani
virus
least
ebv
express
sever
protein
differ
viral
life
cycl
stage
full
spectrum
antibodi
respons
virus
infect
cours
need
explor
perhap
use
protein
array
method
novel
antigen
discoveri
overcom
limit
current
techniqu
